Загрузка...
Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
Triple negative breast cancer (TNBC) is an aggressive breast cancer with historically poor outcomes, primarily due to the lack of effective targeted therapies. The tumor molecular heterogeneity of TNBC has been well recognized, yet molecular subtype driven therapy remains lacking. While neoadjuvant...
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7352772/ https://ncbi.nlm.nih.gov/pubmed/32486021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12061404 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|